(Alliance News) - Stock prices in London were modestly lower at midday on Friday, with sentiment cautious ahead of US inflation data and the Munich Security Conference in focus. Read More
(Alliance News) - NatWest beats annual earnings expectations and boosts shareholder returns, while AstraZeneca reports positive late-stage trial data for Breztri in asthma, as UK retail footfall improves from a weak Christmas period but remains below last year's levels. Read More
(Alliance News) - Stock prices in London closed mixed on Wednesday, following news that the US labour market added almost double the amount of jobs expected last month. Read More
(Alliance News) - Stock prices in London opened lower on Tuesday, as a heavy slate of company results weighed on sentiment, with weakness in heavyweight stocks offsetting pockets of strength elsewhere in the market. Read More
(Alliance News) - AstraZeneca PLC on Tuesday declared a higher total dividend, as it posted increased revenue and profit for 2025 and hailed its "harmonised listing structure" following its recent debut on the New York Stock Exchange. Read More
(Alliance News) - BP suspends its share buyback programme as the oil major seeks to strengthen its balance sheet, while Barclays posts higher annual profit and earnings per share, and AstraZeneca lifts revenue and profit for 2025 while guiding for further growth in 2026. Read More
(Alliance News) - Stock prices in London were lower at midday on Tuesday, as an earlier rally in the FTSE 100, which sent it to a new intraday record, faded while the price of gold rebounded after recent falls. Read More
(Alliance News) - AstraZeneca PLC on Tuesday reported mixed news with progress for its cancer treatment Datroway, while US regulatory authorities requested more information on autoimmune disease drug Saphnelo before progressing its application. Read More
(Alliance News) - AG Barr reports revenue growth and buys soft drink brands Fentimans and Frobishers, while Filtronic expects to meet market expectations despite lower interim earnings. Read More
(Alliance News) - The FTSE 100 shrugged off a weak start, and further volatility in metals and oil prices, to hit new highs on Monday, amid optimism in the manufacturing sector on either side of the pond. Read More
(Alliance News) - Stock prices in London were mixed at midday on Monday, as the FTSE 100 recovered from its earlier fall as the decline in metal prices eased. Read More
(Alliance News) - AstraZeneca PLC on Monday said Imfinzi, in combination with chemotherapy, has been recommended for approval in the EU for the treatment of adult patients with resectable, early-stage and locally advanced gastric and gastroesophageal junction cancers. Read More
(Alliance News) - UK annual house price growth rises more than expected in January, while AstraZeneca starts trading in New York and FitzWalter Capital says it does not intend to make an offer for Auction Technology Group. Read More
(Alliance News) - AstraZeneca PLC on Friday said it has expands its weight-management pipeline by collaborating with China's CSPC Pharmaceuticals Group Ltd to develop next-generation injectable therapies for obesity and type 2 diabetes. Read More
(Alliance News) - Stock prices in London opened mixed on Friday, with the FTSE 100 little changed as investors digested geopolitical developments around UK-China relations and heavy flow of European economic data, while Asian markets closed lower. Read More